Publicaciones en colaboración con investigadores/as de Fundación Jiménez Díaz (15)

2020

  1. Clinical, Patient-Reported, and Ultrasound Outcomes from an Open-Label, 12-week Observational Study of Certolizumab Pegol in Spanish Patients with Rheumatoid Arthritis with or without Prior Anti-TNF Exposure

    Reumatologia Clinica, Vol. 16, Núm. 5, pp. 345-352

2017

  1. A multicentric study to evaluate the use of relative retention times in targeted proteomics

    Journal of Proteomics, Vol. 152, pp. 138-149

  2. Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

    Arthritis and Rheumatology, Vol. 69, Núm. 1, pp. 77-85

2015

  1. The Spanish biology/disease initiative within the human proteome project: Application to rheumatic diseases

    Journal of Proteomics, Vol. 127, pp. 406-413

2014

  1. Lack of replication of interactions between polymorphisms in rheumatoid arthritis susceptibility: Case-control study

    Arthritis Research and Therapy, Vol. 16, Núm. 1

2013

  1. Spanish human proteome project: Dissection of chromosome 16

    Journal of Proteome Research, Vol. 12, Núm. 1, pp. 112-122

2009

  1. Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-κB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility

    Arthritis Research and Therapy, Vol. 11, Núm. 2

  2. Genetic variation in the nuclear factor κB pathway in relation to susceptibility to rheumatoid arthritis

    Annals of the Rheumatic Diseases, Vol. 68, Núm. 4, pp. 579-583

  3. Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir

    AIDS, Vol. 23, Núm. 6, pp. 689-696

  4. Lack of association with rheumatoid arthritis of selected polymorphisms in 4 candidate genes: CFH, CD209, Eotaxin-3, and MHC2TA

    Journal of Rheumatology, Vol. 36, Núm. 8, pp. 1590-1595

  5. Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors

    Arthritis and Rheumatism, Vol. 60, Núm. 9, pp. 2558-2564

2008

  1. Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis

    Arthritis and Rheumatism, Vol. 58, Núm. 5, pp. 1264-1274

  2. Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens

    HIV Clinical Trials, Vol. 9, Núm. 5, pp. 309-313

  3. Prevalence, risk factors, and impact of knee pain suggesting osteoarthritis in Spain

    Clinical and Experimental Rheumatology, Vol. 26, Núm. 2, pp. 324-332

2007

  1. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: A randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator

    Arthritis and Rheumatism, Vol. 56, Núm. 2, pp. 555-567